3fq9: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
[[Image:3fq9. | [[Image:3fq9.png|left|200px]] | ||
<!-- | <!-- | ||
| Line 12: | Line 12: | ||
===Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications=== | ===Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications=== | ||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_19773552}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 19773552 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_19773552}} | |||
==About this Structure== | ==About this Structure== | ||
3FQ9 is a 4 chains structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FQ9 OCA]. | 3FQ9 is a 4 chains structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FQ9 OCA]. | ||
==Reference== | |||
<ref group="xtra">PMID:19773552</ref><references group="xtra"/> | |||
[[Category: Katsoyannis, P.]] | [[Category: Katsoyannis, P.]] | ||
[[Category: Phillips, N.]] | [[Category: Phillips, N.]] | ||
| Line 37: | Line 46: | ||
[[Category: Therapeutic implication]] | [[Category: Therapeutic implication]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Nov 25 09:31:43 2009'' | ||
Revision as of 07:31, 25 November 2009
Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
Template:ABSTRACT PUBMED 19773552
About this Structure
3FQ9 is a 4 chains structure. Full crystallographic information is available from OCA.
Reference
- Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications. J Biol Chem. 2009 Nov 13;284(46):32178-87. Epub 2009 Sep 22. PMID:19773552 doi:10.1074/jbc.M109.028399
Page seeded by OCA on Wed Nov 25 09:31:43 2009
Proteopedia Page Contributors and Editors (what is this?)
Categories:
- Pages with broken file links
- Katsoyannis, P.
- Phillips, N.
- Wan, Z L.
- Weiss, M A.
- Whittaker, J.
- Whittaker, L.
- Xu, B.
- Zhao, M.
- Carbohydrate metabolism
- Cleavage on pair of basic residue
- Diabetes mellitus
- Disease mutation
- Glucose metabolism
- Hormone
- Insulin design
- Pharmaceutical
- Rational
- Receptor-binding
- Secreted
- Structure
- Therapeutic implication
